Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients.

Brunasso, Alexandra M G

Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients. [electronic resource] - Acta dermato-venereologica Jan 2011 - 44-9 p. digital

Publication Type: Journal Article

1651-2057

10.2340/00015555-0959 doi


Adalimumab
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents--adverse effects
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Dermatologic Agents--adverse effects
Etanercept
Female
Humans
Immunoglobulin G--adverse effects
Infliximab
Male
Middle Aged
Psoriasis--drug therapy
Receptors, Tumor Necrosis Factor--therapeutic use
Young Adult